Susquehanna International Group, LLP Sangamo Therapeutics, Inc Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

A detailed history of Susquehanna International Group, LLP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 32,448 shares of SGMO stock, worth $11,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,448

Previous 106,259 69.46%

Holding current value

$11,681

Previous $57,000 63.16%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$0.42 - $1.38 $31,000 - $101,859	-73,811 Reduced 69.46%	32,448 $21,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $11,038 - $23,181	36,796 Added 52.97%	106,259 $57,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $134,271 - $340,307	-231,502 Reduced 76.92%	69,463 $41,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $19,805 - $31,046	17,843 Added 6.3%	300,965 $391,000
Q1 2023 May 16, 2023	BUY	$1.66 - $3.67 $221,364 - $489,401	133,352 Added 89.04%	283,122 $498,000

Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $548,811 - $1 Million	-198,127 Reduced 56.95%	149,770 $470,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $705,549 - $1.06 Million	165,234 Added 90.46%	347,897 $1.71 Million
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $94,710 - $179,313	-28,875 Reduced 13.65%	182,663 $757,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $272,064 - $406,796	-52,020 Reduced 19.74%	211,538 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $495,574 - $745,740	67,980 Added 34.76%	263,558 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $273,354 - $364,371	30,339 Added 18.36%	195,578 $1.76 Million
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $230,564 - $286,561	-22,671 Reduced 12.06%	165,239 $1.98 Million
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $998,120 - $1.56 Million	-91,739 Reduced 32.81%	187,910 $2.36 Million
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $477,181 - $939,887	-51,699 Reduced 15.6%	279,649 $4.36 Million
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $1.22 Million - $1.62 Million	-129,621 Reduced 28.12%	331,348 $3.13 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $174,271 - $331,985	28,063 Added 6.48%	460,969 $4.13 Million
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $890,284 - $1.56 Million	-176,294 Reduced 28.94%	432,906 $2.76 Million
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $172,404 - $251,198	-21,470 Reduced 3.4%	609,200 $5.1 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $103,866 - $140,248	-11,477 Reduced 1.79%	630,670 $5.71 Million
Q2 2019 Aug 16, 2019	BUY	$8.75 - $13.03 $397,320 - $591,666	45,408 Added 7.61%	642,147 $6.92 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $4.02 Million - $5.99 Million	459,703 Added 335.46%	596,739 $6.43 Million
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $3.54 Million - $5.88 Million	-459,195 Reduced 77.02%	137,036 $1.31 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $612,757 - $1.07 Million	64,433 Added 12.12%	596,231 $6.85 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $1.57 Million - $2.29 Million	120,025 Added 29.15%	531,798 $9.01 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $4.29 Million - $6.12 Million	308,921 Added 300.35%	411,773 $5.85 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $3.48 Million - $5.49 Million	-208,478 Reduced 66.96%	102,852 $1.95 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $408,354 - $610,772	-35,203 Reduced 10.16%	311,330 $5.11 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $2.91 Million - $5.2 Million	346,533	346,533 $5.2 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Sangamo Therapeutics, Inc Transaction History